[PDF][PDF] Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma

L Au, E Hatipoglu, MR de Massy, K Litchfield, G Beattie… - Cancer cell, 2021 - cell.com
ADAPTeR is a prospective, phase II study of nivolumab (anti-PD-1) in 15 treatment-naive
patients (115 multiregion tumor samples) with metastatic clear cell renal cell carcinoma …

The landscape of genomic alterations across childhood cancers

SN Gröbner, BC Worst, J Weischenfeldt, I Buchhalter… - Nature, 2018 - nature.com
Pan-cancer analyses that examine commonalities and differences among various cancer
types have emerged as a powerful way to obtain novel insights into cancer biology. Here we …

The whole-genome landscape of medulloblastoma subtypes

PA Northcott, I Buchhalter, AS Morrissy, V Hovestadt… - Nature, 2017 - nature.com
Current therapies for medulloblastoma, a highly malignant childhood brain tumour, impose
debilitating effects on the developing child, and highlight the need for molecularly targeted …

CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing

E Talevich, AH Shain, T Botton… - PLoS computational …, 2016 - journals.plos.org
Germline copy number variants (CNVs) and somatic copy number alterations (SCNAs) are
of significant importance in syndromic conditions and cancer. Massively parallel sequencing …

Whole chromosome loss and genomic instability in mouse embryos after CRISPR-Cas9 genome editing

S Papathanasiou, S Markoulaki, LJ Blaine… - Nature …, 2021 - nature.com
Karyotype alterations have emerged as on-target complications from CRISPR-Cas9 genome
editing. However, the events that lead to these karyotypic changes in embryos after Cas9 …

Genome-informed targeted therapy for osteosarcoma

LC Sayles, MR Breese, AL Koehne, SG Leung, AG Lee… - Cancer discovery, 2019 - AACR
Osteosarcoma is a highly aggressive cancer for which treatment has remained essentially
unchanged for more than 30 years. Osteosarcoma is characterized by widespread and …

A Big Bang model of human colorectal tumor growth

A Sottoriva, H Kang, Z Ma, TA Graham, MP Salomon… - Nature …, 2015 - nature.com
What happens in early, still undetectable human malignancies is unknown because direct
observations are impractical. Here we present and validate a'Big Bang'model, whereby …

[PDF][PDF] Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes

SC Dentro, I Leshchiner, K Haase, M Tarabichi… - Cell, 2021 - cell.com
Intra-tumor heterogeneity (ITH) is a mechanism of therapeutic resistance and therefore an
important clinical challenge. However, the extent, origin, and drivers of ITH across cancer …

[HTML][HTML] Computational methods for detecting copy number variations in cancer genome using next generation sequencing: principles and challenges

B Liu, CD Morrison, CS Johnson, DL Trump, M Qin… - Oncotarget, 2013 - ncbi.nlm.nih.gov
Accurate detection of somatic copy number variations (CNVs) is an essential part of cancer
genome analysis, and plays an important role in oncotarget identifications. Next generation …

Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy

M Angelova, P Charoentong, H Hackl, ML Fischer… - Genome biology, 2015 - Springer
Background While large-scale cancer genomic projects are comprehensively characterizing
the mutational spectrum of various cancers, so far little attention has been devoted to either …